TOI News

The Oncology Institute Launches Lung Cancer Center of Excellence in Florida Led by International Oncology Expert Dr. Edgardo Santos

TOI

(NASDAQ:TOI) CERRITOS, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), a leading value-based oncology practice, today announced the launch of its Lung Cancer Center of Excellence in Fort Lauderdale, Florida. The new center will be led by world-renowned thoracic oncologist Dr. Edgardo S. Santos Castillero, whose career has been defined by groundbreaking research, clinical excellence, and a deep commitment to patient care.

September 2, 2025Announcement
Read more →

The Oncology Institute Reports Second Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance

TOI

CERRITOS, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended June 30, 2025.

August 13, 2025Earnings
Read more →

The Oncology Institute Files For Stock Shelf Of Up to $50M

TOI

June 6, 2025
Read more →

The Oncology Institute To Join Russell 2000 And Russell 3000 Indexes

TOI

June 3, 2025
Read more →

Oncology Institute Affirms FY2025 Sales Guidance of $460.00M-$480.00M vs $482.80M Est

TOI

May 14, 2025
Read more →

The Oncology Institute Q1 GAAP EPS $(0.21) Up From $(0.22) YoY, Sales $104.41M Up From $94.67M YoY

TOI

May 14, 2025
Read more →

The Oncology Institute Files Prospectus For The ~Resale Of Up To 27.92M Shares Of Common Stock By Selling Securityholders

TOI

May 9, 2025
Read more →

The Oncology Institute To Present at Upcoming ASCO Annual Meeting On Cancer Care Model Outcomes

TOI

May 8, 2025
Read more →

The Oncology Institute Announces Enterprise-wide Expansion Of Strategic Partnership With Helios Clinical Research

TOI

April 22, 2025
Read more →

The Oncology Institute Expects FY2025 Revenue Of $460M-$480M Vs. Consensus Of $482.80M

TOI

March 24, 2025
Read more →

The Oncology Institute Q4 2024 EPS $(0.14) Comapred to $(0.21) YoY, Sales $100.27M Vs. $85.79M YoY

TOI

March 24, 2025
Read more →

The Oncology Institute Entered Into A Securities Purchase Agreement With Accredited Investors For A Private Placement In Gross Proceeds Of Approximately $16.5M

TOI

March 24, 2025
Read more →

The Oncology Institute Becomes Certified As A Patient Safety Organization

TOI

September 12, 2022
Read more →